Reading the tape
NASDAQ: IRMD
IRadimed Corporation
Healthcare · Medical - Devices
Market Cap
$1.07B
52w High
$107.90
52w Low
$50.31
P/E
47.28
Volume
156.65K
Outstanding Shares
12.78M
Price vs Fundamentals
Why The Stock Is Moving
Optimism is getting priced inModerate confidence
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
1Y Price: 59.21%Revenue (TTM): 14.43%FCF (TTM): -0.01%P/FCF: 77th pct
What changed
The stock rose 59.21% over the last year. Revenue grew 14.43% over the trailing twelve months. Operating margin moved from 29.99% to 31.2%. Free cash flow declined 0.01% over the trailing twelve months.
What the market seems to be pricing
The stock is trading toward the richer end of its historical P/FCF range (77th percentile) while business metrics are improving. More of the upside is already embedded in the multiple now.
What would invalidate this read
Operating margin is at 31.2% — continued expansion would be needed to justify the premium. Revenue growth of 14.43% is encouraging, but any deceleration puts the stretched multiple at risk. This read changes if revenue, margins, and cash flow continue to improve faster than expected — in that case the richer multiple could still prove conservative.
Company profile
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally.
CEORoger E. Susi
SectorHealthcare
IndustryMedical - Devices
Employees160
IPO dateJul 16, 2014
Valuation
Forward P/E—
EV/EBITDA41.59
Enterprise value$1.19B
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Revenue growth17.03%
Gross margin76.75%▼0.25%vs FY2024
Operating margin31.2%▲4.03%vs FY2024
ROE23.76%▲7.24%vs FY2024
Analyst consensus
RatingBuy
Target price$120.00▲43.82%
2
Buy
0
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
May 1, 2026
Q2 FY26 · EPS est $0.45 · Revenue est $21.32M
View
Dividends
$1.04/shareQuarterlyAdequateIRMD pays a dividend with a 1.25% dividend yield, growing at 5.67% annually, covered 1.1× by free cash flow.
Dividend Yield
1.25%
Annual Div / Share
$1.04
TTM $1.21
3yr CAGR
+5.67%
Doubles every ~12.6yr
Payout Ratio
66.9%
Adequate
Dividend Growth Rate
3yr CAGR
+5.67%
Dividend Safety
5/10Adequate
Dividend History
Annual dividends paid per share
YearAnnual DivYoY
2025$1.18+162.2%
2024$0.45-73.2%
2023$1.68+68.0%
2022$1.00—
Income Projection
Invest
$
Growth rate:
Reinvest dividends
Today
$12/yr
$1/mo
In 5 yrs
$16/yr+32%
$1/mo
In 10 yrs
$22/yr+74%
$2/mo
| Today | In 5 yrs | In 10 yrs |
|---|---|---|
$12/yr $1/mo | $16/yr+32% $1/mo | $22/yr+74% $2/mo |
Yield-on-cost grows from 1.25% → 2.16% over 10yr